Specialty products: the next challenge for alliances

Area of Science:

• Healthcare Administration
• Supply Chain Management
• Pharmaceutical Economics

Background:

• Group purchasing organizations (GPOs) are evolving.
• The current contract portfolio often lacks specialty products.
• Industry stakeholders need to adapt to changing market dynamics.

Purpose of the Study:

• To highlight the necessity for GPOs to broaden their contract offerings.
• To emphasize the mutual benefits of including specialty products in GPO contracts.
• To analyze the consequences of failing to negotiate value-driven specialty product agreements.

Main Methods:

• Analysis of current GPO contract trends.
• Review of stakeholder benefits in specialty product procurement.
• Assessment of market share implications for suppliers.

Main Results:

• Expanding GPO contracts to include specialty products offers significant advantages.
• Collaborative agreements between GPOs, manufacturers, and hospitals drive industry growth.
• Failure to negotiate benefits for all parties leads to financial losses and reduced market access.

Conclusions:

• GPOs must proactively integrate specialty products into their contract portfolios.
• Strategic negotiation of specialty product agreements is crucial for realizing cost savings and market opportunities.
• The future success of the healthcare supply chain depends on inclusive and mutually beneficial contracting.